Proceeds from the deal, which hands Novartis global rights to a technology developed by Sironax, will help advance three candidates that the startup says have “best-in-class” potential.

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective blood-brain barrier. The deal comes as Novartis weathers several pipeline set...

As China's biotech sector accelerates, executives at Sironax, Candid, InduPro and others weigh in on work-ethic gaps with US counterparts.

Reported Wednesday, Jul 9 - 8:08am EDT (TheFly subscription required to read more.)

Sironax has announced an agreement with Novartis to boost its innovative Brain Delivery Module, aimed at improving therapeutic access to the brain.

Sironax enters a strategic collaboration with Novartis, allowing the pharmaceutical giant an exclusive option to acquire Sironax's innovative Brain Delivery Module, enhancing treatment options for neurological diseases.